Serial myocardial perfusion imaging: Defining a significant change and targeting management decisions

JACC: Cardiovascular Imaging

Volumn 7, Issue 1, 2014, Pages 79-96

  Iskandrian, Ami E ^a   Hage, Fadi G ^a,b   Shaw, Leslee J ^c   Mahmarian, John J ^d   Berman, Daniel S ^e  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

coronary artery disease; myocardial ischemia; myocardial perfusion imaging; single photon emission tomography; stress testing

Indexed keywords

BIOLOGICAL FACTOR; TRACER;

ARTICLE; CLINICAL DECISION MAKING; COMPUTER PROGRAM; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL INFORMATION; MYOCARDIAL PERFUSION IMAGING; PATIENT CARE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); CORONARY ARTERY DISEASE; DECISION MAKING; DISEASE MANAGEMENT; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ARTERY DISEASE; DECISION MAKING; DISEASE MANAGEMENT; HUMANS; MYOCARDIAL PERFUSION IMAGING; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84892542017     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.05.022     Document Type: Review

References (58)

1. L.J. Shaw, F.G. Hage, D.S. Berman, R. Hachamovitch, and A. Iskandrian Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be? J Nucl Cardiol 19 2012 1026 1043
2. G.J. Dehmer, D. Weaver, and M.T. Roe et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011 J Am Coll Cardiol 60 2012 2017 2031
3. F.G. Hage, A. Gupta, and A.E. Iskandrian Risk assessment in the era of high-speed myocardial perfusion imaging J Nucl Cardiol 19 2012 1102 1105
4. E.G. Depuey, J.J. Mahmarian, and T.D. Miller et al. Patient-centered imaging J Nucl Cardiol 19 2012 185 215
5. R. Nakazato, D.S. Berman, and S.W. Hayes et al. Myocardial perfusion imaging with a solid-state camera: simulation of a very low dose imaging protocol J Nucl Med 54 2013 373 379
6. F.G. Hage, F.M. Iqbal, and A.E. Iskandrian Serial testing A.E. Iskandrian, E.V. Garcia, Atlas of Nuclear Cardiology. Imaging Companion to Braunwald's Heart Disease 2012 Elsevier Philadelphia, PA 158 180
7. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones et al. Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 188 197
8. L.H. Young, F.J. Wackers, and D.A. Chyun et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial JAMA 301 2009 1547 1555
9. W.E. Boden, R.A. O'Rourke, and K.K. Teo et al. Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
10. BARI 2D Study Group, R.L. Frye, P. August, and M.M. Brooks et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
11. L.J. Shaw, J.H. Mieres, and R.H. Hendel et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial Circulation 124 2011 1239 1249
12. A. Rozanski, H. Gransar, and S.W. Hayes et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009 J Am Coll Cardiol 61 2013 1054 1065
13. A.E. Iskandrian, and F.G. Hage Declining frequency of ischemia detection using stress myocardial perfusion imaging J Am Coll Cardiol 61 2013 1066 1068
14. L.J. Shaw, D.S. Berman, and D.J. Maron et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
15. L.J. Shaw, M.D. Cerqueira, and M.M. Brooks et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial J Nucl Cardiol 19 2012 658 669
16. J.J. Mahmarian, H.A. Dakik, and N.G. Filipchuk et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction J Am Coll Cardiol 48 2006 2458 2467
17. J.J. Mahmarian, N.L. Fenimore, and G.F. Marks et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography J Am Coll Cardiol 24 1994 25 32
18. H.A. Dakik, N.S. Kleiman, and J.A. Farmer et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study Circulation 98 1998 2017 2023
19. J.M. Mostaza, M.V. Gomez, and F. Gallardo et al. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels J Am Coll Cardiol 35 2000 76 82
20. J.E. Udelson, V. Dilsizian, and R.J. Laham et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease Circulation 102 2000 1605 1610
21. D.S. Berman, X. Kang, and E.F. Schisterman et al. Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy J Nucl Cardiol 8 2001 428 437
22. S.M. Burns, S. Brown, C.A. White, S. Tait, L. Sharples, and P.M. Schofield Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization Am J Cardiol 87 2001 861 867
23. R. Taillefer, A.W. Ahlberg, and Y. Masood et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging J Am Coll Cardiol 42 2003 1475 1483
24. R.G. Schwartz, T.A. Pearson, and V.G. Kalaria et al. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial J Am Coll Cardiol 42 2003 600 610
25. C.L. Grines, M.W. Watkins, and J.J. Mahmarian et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina J Am Coll Cardiol 42 2003 1339 1347
26. T.D. Henry, B.H. Annex, and G.R. McKendall et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis Circulation 107 2003 1359 1365
27. G.J. Zoghbi, T. Htay, R. Aqel, L. Blackmon, J. Heo, and A.E. Iskandrian Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging J Am Coll Cardiol 47 2006 2296 2302
28. R.A. Aqel, F.G. Hage, and G.J. Zoghbi et al. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients Am J Cardiol 101 2008 1328 1333
29. J.J. Mahmarian, M.D. Cerqueira, and A.E. Iskandrian et al. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial J Am Coll Cardiol Img 2 2009 959 968
30. R. Venkataraman, L. Belardinelli, B. Blackburn, J. Heo, and A.E. Iskandrian A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images J Am Coll Cardiol Img 2 2009 1301 1309
31. J. Roncalli, F. Mouquet, and C. Piot et al. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial Eur Heart J 32 2011 1748 1757
32. R. Venkataraman, W. Aljaroudi, L. Belardinelli, J. Heo, and A.E. Iskandrian The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality J Nucl Cardiol 18 2011 456 462
33. J.C. Lee, J.F. Fraser, and A.G. Barnett et al. Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis J Nucl Cardiol 19 2012 474 481
34. A. Farzaneh-Far, H.R. Phillips, and L.K. Shaw et al. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction J Am Coll Cardiol Img 5 2012 715 724
35. R. Venkataraman, J. Chen, and E.V. Garcia et al. Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease Am J Cardiol 110 2012 1440 1445
36. E.C. Perin, J.T. Willerson, and C.J. Pepine et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial JAMA 307 2012 1717 1726
37. A.F. Parisi, P.M. Hartigan, and E.D. Folland Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) study J Am Coll Cardiol 30 1997 1256 1263
38. S. Sdringola, K. Nakagawa, and Y. Nakagawa et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease J Am Coll Cardiol 41 2003 263 272
39. R.C. Hendel, D.S. Berman, and M.F. Di Carli et al. ACCF/ASNC/ACR/AHA/ASE/ SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine J Am Coll Cardiol 53 2009 2201 2229
40. D.S. Berman, X. Kang, and H. Gransar et al. Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis J Nucl Cardiol 16 2009 45 53
41. A.E. Iskandrian, E.V. Garcia, T. Faber, and J.J. Mahmarian Automated assessment of serial SPECT myocardial perfusion images J Nucl Cardiol 16 2009 6 9
42. T.A. Holly, B.G. Abbott, and M. Al-Mallah et al. Single photon-emission computed tomography J Nucl Cardiol 17 2010 941 973
43. F.J. Wackers Quantification of SPECT myocardial perfusion images A.E. Iskandrian, E.V. Garcia, Nuclear Cardiac Imaging: Principles and Applications 4th edition 2008 Oxford University Press New York, NY 102 116
44. Y. Xu, S. Hayes, and I. Ali et al. Automatic and visual reproducibility of perfusion and function measures for myocardial perfusion SPECT J Nucl Cardiol 17 2010 1050 1057
45. M.D. Cerqueira, P. Nguyen, P. Staehr, S.R. Underwood, and A.E. Iskandrian Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging: integrated ADVANCE-MPI trial results J Am Coll Cardiol Cardiol Img 1 2008 307 316
46. K.L. Gould Coronary flow reserve and pharmacologic stress perfusion imaging: beginnings and evolution J Am Coll Cardiol Img 2 2009 664 669
47. D.S. Berman, J. Maddahi, and B.K. Tamarappoo et al. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography J Am Coll Cardiol 61 2013 469 477
48. A.P. Pazhenkottil, R. Nkoulou, and S. Kuest et al. Absolute coronary blood flow and coronary flow reserve assessed by gated SPECT with cadmium-zinc-telluride detectors: a direct comparison with 13N-ammonia PET J Am Coll Cardiol 61 2013 E1005
49. P.J. Slomka, H. Nishina, and D.S. Berman et al. Automatic quantification of myocardial perfusion stress-rest change: a new measure of ischemia J Nucl Med 45 2004 183 191
50. F. Iqbal, W. Aljaroudi, A. Sweeney, J. Heo, A.E. Iskandrian, and F.G. Hage Comparison of automated quantitative myocardial perfusion imaging utilizing three software packages J Am Coll Cardiol 61 2013 E1052
51. A. Wolak, P.J. Slomka, and M.B. Fish et al. Quantitative myocardial-perfusion SPECT: comparison of three state-of-the-art software packages J Nucl Cardiol 15 2008 27 34
52. G.R. Dagenais, J. Lu, and D.P. Faxon et al. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial J Am Coll Cardiol 61 2013 702 711
53. A.E. Iskandrian, T.M. Bateman, and L. Belardinelli et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial J Nucl Cardiol 14 2007 645 658
54. A.S. Iskandrian, J. Heo, B. Kong, and E. Lyons Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients J Am Coll Cardiol 14 1989 1477 1486
55. T. Nguyen, J. Heo, J.D. Ogilby, and A.S. Iskandrian Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography J Am Coll Cardiol 16 1990 1375 1383
56. J.J. Mahmarian State of the art for coronary artery disease: thallium-201 B. Zaret, G.A. Beller, Nuclear Cardiology: State of the Art and Future Directions 2nd edition 1999 Mosby St. Louis, MO 237 272
57. A.E. Iskandrian, E.V. Garcia, and T. Faber Analysis of serial images: a challenge and an opportunity J Nucl Cardiol 15 2008 23 26
58. J.J. Mahmarian, L.A. Moye, M.S. Verani, M.F. Bloom, and C.M. Pratt High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography Am J Cardiol 75 1995 1116 1119